APEX Ventures

APEX Ventures is a prominent venture capital firm headquartered in Vienna, Austria, with a distinct focus on early-stage deep-tech, industrial-tech, and medical-tech companies. The firm positions itself as a key partner for innovative startups emerging from European research and development, aiming to transform groundbreaking scientific discoveries into commercially viable solutions. Their investment philosophy centers on identifying disruptive technologies with significant market potential, providing not only capital but also strategic guidance and access to a robust network of industry experts and co-investors.

The firm primarily targets Seed and Series A funding rounds, indicating a commitment to supporting companies from their nascent stages through initial growth phases. APEX Ventures typically deploys initial investment tickets ranging from EUR 0.5 million to EUR 3 million. This translates to approximately $0.54 million to $3.24 million USD, based on recent exchange rates. Beyond the initial cheque, APEX Ventures is known for its capacity to provide follow-on funding, supporting its portfolio companies as they scale and achieve subsequent milestones. Their hands-on approach involves active engagement with founders, assisting with business development, talent acquisition, and international expansion.

APEX Ventures manages multiple specialized funds, underscoring its focused investment thesis. These include the APEX One Fund, with EUR 40 million dedicated to deep-tech, the APEX Two Fund, which commands EUR 60 million for broader deep-tech investments, and the APEX MedTech Fund, specifically allocated EUR 50 million for medical technology innovations. Collectively, these funds represent a significant capital pool dedicated to their niche sectors, allowing them to make substantial commitments to promising ventures. The firm's strategic deployment of capital across these specialized vehicles highlights its expertise and deep understanding of the unique challenges and opportunities within the deep-tech and medical fields.

The firm's strong presence in the European startup ecosystem, combined with its specialized focus and substantial capital resources, makes APEX Ventures a significant player for early-stage deep-tech and medical startups seeking both funding and strategic partnership.